Related Experiment Videos
Anticoagulation with sodium warfarin in children: effect of a loading regimen
J J Doyle1, G Koren, M Y Cheng
1Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Determining optimal warfarin dosage in children is complex. Standardized loading regimens show significant variability in prothrombin time (PT) response, indicating individual factors are crucial for predicting warfarin efficacy.
Area of Science:
- Pediatric Pharmacology
- Pharmacokinetics
- Thrombosis Management
Background:
- Warfarin is a critical anticoagulant medication used in pediatric patients.
- Accurate warfarin dosing is essential to prevent thromboembolic events while minimizing bleeding risk.
- Current dosing guidelines for children often result in unpredictable responses.
Purpose of the Study:
- To evaluate warfarin dose requirements in pediatric patients.
- To identify factors influencing warfarin's anticoagulant effect in children.
- To assess the predictability of prothrombin time (PT) based on standard dosing regimens.
Main Methods:
- Retrospective analysis of 26 pediatric patients treated with warfarin.
- Prospective treatment of 15 children using a derived dosing regimen (0.2 mg/kg/day for 2 days).
- Correlation analysis between warfarin dose and prothrombin time (PT) at day 2.
Main Results:
- Prothrombin time (PT) at day 2 significantly correlated with initial warfarin doses (p < 0.001).
- A standardized loading regimen produced a wide range of PT values.
- Patient age, weight, or body surface area did not accurately predict individual PT response.
- Warfarin dose accounted for only 40% of the variability in PT.
Conclusions:
- Standardized warfarin loading regimens in children lead to highly variable prothrombin time responses.
- Predicting an individual child's response to warfarin based on morphometric measurements is unreliable.
- Further research is needed to identify biomarkers or alternative methods for personalized warfarin dosing in pediatric populations.
Abstract:
To assess dose requirements of warfarin in children, we analyzed retrospectively the treatment of 26 patients with the drug. Subsequently we treated 15 children, prospectively, with a regimen derived from our retrospective analysis (0.2 mg/kg/day for 2 days). In the retrospective analysis we found the prothrombin time (PT) at day 2 to correlate significantly with the dose given on day 0 (p less than 0.001) and with the cumulative dose on days 0 and 1 (p less than 0.001), but the standardized loading regimen resulted in a wide range of PTs independent of age, weight, or body surface area. The warfarin dose contributes only 40% of the variability in PT; an individual child's response to warfarin cannot be predicted accurately on the basis of the usual morphometric measurements.